Cedric Francois - Apr 25, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Apr 25, 2022
Transactions value $
-$1,236,304
Form type
4
Date filed
12/21/2022, 03:13 PM
Previous filing
Feb 14, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Other $0 -12.5K -1.31% $0.00 943K Apr 25, 2022 Direct F1
transaction APLS Common Stock Options Exercise $75.3K +28.2K +2.99% $2.67* 972K Dec 19, 2022 Direct F2
transaction APLS Common Stock Options Exercise $56.4K +15K +1.54% $3.76* 987K Dec 19, 2022 Direct
transaction APLS Common Stock Options Exercise $100K +6.69K +0.68% $14.95 993K Dec 19, 2022 Direct
transaction APLS Common Stock Sale -$195K -3.75K -0.38% $51.97 990K Dec 19, 2022 Direct F2, F3
transaction APLS Common Stock Sale -$1.27M -24.4K -2.47% $52.07 965K Dec 19, 2022 Direct F2, F4
holding APLS Common Stock 300K Apr 25, 2022 The Francois Grossi Trust F5
holding APLS Common Stock 234K Apr 25, 2022 The Francois-DuBois Educational Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -28.2K -5.9% $0.00 450K Dec 19, 2022 Common Stock 28.2K $2.67 Direct F2, F7
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -15K -5.48% $0.00 259K Dec 19, 2022 Common Stock 15K $3.76 Direct F8
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -6.69K -2.39% $0.00 273K Dec 19, 2022 Common Stock 6.69K $14.95 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents the cancellation of a PSU awards granted on 01/28/2021 that was originally reported in table I upon grant. The performance metrics were not met.
F2 This is a scheduled exercise & sale from 10b5-1 plan adopted September 13, 2022 .
F3 Sale price within range of $1. Min. $50.695 - Max. $51.680
F4 Sale price within range of $1. Min. $51.695 - Max. $52.400
F5 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F6 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F7 This option was granted on December 5, 2013 and fully vested.
F8 This option was granted on February 8, 2016 and fully vested.
F9 This option was granted on February 16, 2018 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.